AVIR Competitors & Alternatives
Compare Atea Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
AVIR
Main Stock$4.04
Tradestie Score
49
Market Cap
$228.55M
Revenue Growth
3.0%
Analyst Upside
+110.4%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.16
|
$371.64M | - | 61 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.37
|
$354.45M | - | 47 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$38.73
|
$353.70M | 394.2 | 48 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.41
|
$350.98M | - | 68 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.75
|
$332.96M | - | 44 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.46
|
$328.62M | - | 49 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$6.87
|
$307.12M | - | 58 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.03
|
$304.12M | - | 56 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.59
|
$297.23M | - | 45 | Compare |
|
OMER
Omeros Corporation
|
$16.57
|
$281.75M | 13.3 | 66 | Compare |
More AVIR Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry